BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34887112)

  • 1. Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases.
    Dasari S; Kohlhagen MC; Dispenzieri A; Willrich MAV; Snyder MR; Kourelis TV; Lust JA; Mills JR; Kyle RA; Murray DL
    Mayo Clin Proc; 2022 Feb; 97(2):294-307. PubMed ID: 34887112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
    Smith J; Raines G; Schneider HG
    Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of utilization of serum protein analysis: role of the electronic medical record in promoting consultation by pathology.
    Zia HM; Singh G
    Am J Clin Pathol; 2013 Jun; 139(6):793-7. PubMed ID: 23690123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation.
    Willrich MA; Ladwig PM; Andreguetto BD; Barnidge DR; Murray DL; Katzmann JA; Snyder MR
    Clin Chem Lab Med; 2016 Jun; 54(6):1085-93. PubMed ID: 26812875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing Mass Spectrometry to Detect and Isotype Monoclonal Proteins in Urine: Comparison to Electrophoretic Methods.
    Moonen DH; Kohlhagen M; Dasari S; Willrich MA; Kourelis T; Dispenzieri A; Murray DL
    Clin Chem; 2023 Jul; 69(7):746-753. PubMed ID: 37228061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.
    Mills JR; Kohlhagen MC; Dasari S; Vanderboom PM; Kyle RA; Katzmann JA; Willrich MA; Barnidge DR; Dispenzieri A; Murray DL
    Clin Chem; 2016 Oct; 62(10):1334-44. PubMed ID: 27540026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry.
    Sepiashvili L; Kohlhagen MC; Snyder MR; Willrich MAV; Mills JR; Dispenzieri A; Murray DL
    Clin Chem; 2019 Aug; 65(8):1015-1022. PubMed ID: 31171529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
    Böer K; Deufel T
    Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance.
    Rozenova K; Willrich M; Snyder M; Dasari S; Kourelis T; Rajkumar SV; Kumar S; Dispenzieri A; Murray DL
    J Appl Lab Med; 2023 Jul; 8(4):742-750. PubMed ID: 37232112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
    Wood PB; McElroy YG; Stone MJ
    Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
    Levinson SS
    Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should routine laboratories stop doing screening serum protein electrophoresis and replace it with screening immune-fixation electrophoresis? No quick fixes: Counterpoint.
    Smith JD; Raines G; Schneider HG
    Clin Chem Lab Med; 2016 Jun; 54(6):967-71. PubMed ID: 26677889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin kappa/lambda ratios in monoclonal gammopathies.
    Eckold J; Poenisch W; Drogies T; Kratzsch J; Teupser D; Thiery J; Bruegel M
    Clin Lab; 2014; 60(9):1491-500. PubMed ID: 25291945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies.
    Hill PG; Forsyth JM; Rai B; Mayne S
    Clin Chem; 2006 Sep; 52(9):1743-8. PubMed ID: 16858075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
    Greil C; Ihorst G; Gaiser F; Salzer U; Bisse E; Kastritis E; Ludwig H; Wäsch R; Engelhardt M
    Eur J Haematol; 2017 Nov; 99(5):449-458. PubMed ID: 28886228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.
    Ludwig H; Milosavljevic D; Zojer N; Faint JM; Bradwell AR; Hübl W; Harding SJ
    Leukemia; 2013 Jan; 27(1):213-9. PubMed ID: 22955329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population.
    Abadie JM; Bankson DD
    Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
    Mellors PW; Dasari S; Kohlhagen MC; Kourelis T; Go RS; Muchtar E; Gertz MA; Kumar SK; Buadi FK; Willrich MAV; Lust JA; Kapoor P; Lacy MQ; Dingli D; Hwa Y; Fonder A; Hobbs M; Hayman S; Warsame R; Leung NR; Lin Y; Gonsalves W; Siddiqui M; Kyle RA; Rajkumar SV; Murray DL; Dispenzieri A
    Blood Cancer J; 2021 Mar; 11(3):50. PubMed ID: 33664227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
    Jaskowski TD; Litwin CM; Hill HR
    Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of serum M-protein in acetonitrile precipitates by MALDI-TOF mass spectrometry: A novel, low-cost methodology.
    Mehra N; Gopisetty G; Subramani J; Dhanasekar S; Rajamanickam A; Perumal Kalaiyarasi J; Karunakaran P; Kannan K; Rajaraman S; Rajkumar T
    Ann Clin Biochem; 2023 Sep; 60(5):339-348. PubMed ID: 37158306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.